Interacting Drugs |
Moclobemide vs Levodopa |
Security Level |
 |
Mechanism |
Levodopa: May enhance the adverse/toxic effect of MAO Inhibitors. Of particular concern is the development of hypertensive reactions when levodopa is used with nonselective MAOI. |
Management |
Consider therapy modification |
Moclobemide vs Levodopa
Post Review about Moclobemide vs Levodopa Click here to cancel reply.
Other Interactions of Moclobemide
Other Interactions of Levodopa
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.